ClinicalTrials.Veeva

Menu

Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome (ReLIPSSO)

C

Centre Hospitalier Universitaire de Nice

Status

Enrolling

Conditions

Dry Eye Syndromes
Severe Dry Eye Syndromes

Treatments

Other: injections of Platelet-Rich Plasma in lacrimal gland

Study type

Interventional

Funder types

Other

Identifiers

NCT06831253
24-AOIP-02
IDRCB (Other Identifier)

Details and patient eligibility

About

The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.

Full description

injections in lacrimal gland four times during the study for each patient

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Platelet counts, and clotting factors in the standarts
  • Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist

Exclusion criteria

  • Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
  • Patients with complete stenosis of both lacrimal meatus in the treated eye

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Injection of Platelet-Rich Plasma (PRP)
Experimental group
Treatment:
Other: injections of Platelet-Rich Plasma in lacrimal gland

Trial contacts and locations

1

Loading...

Central trial contact

Doctor Jean Philippe GROSSE, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems